Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiarrhythmic drugs: from mechanisms to clinical practice.

× No keyword cloud information.

17 in total

1. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

Authors: S E Coplen; E M Antman; J A Berlin; P Hewitt; T C Chalmers
Journal: Circulation Date: 1990-10 Impact factor: 29.690

2. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.

Authors:
Journal: Lancet Date: 1997-11-15 Impact factor: 79.321

Review 3. Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology.

Authors: S G Priori; J Barhanin; R N Hauer; W Haverkamp; H J Jongsma; A G Kleber; W J McKenna; D M Roden; Y Rudy; K Schwartz; P J Schwartz; J A Towbin; A Wilde
Journal: Eur Heart J Date: 1999-02 Impact factor: 29.983

4. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Authors: L M Hondeghem; D J Snyders
Journal: Circulation Date: 1990-02 Impact factor: 29.690

5. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.

Authors: P J Kudenchuk; L A Cobb; M K Copass; R O Cummins; A M Doherty; C E Fahrenbruch; A P Hallstrom; W A Murray; M Olsufka; T Walsh
Journal: N Engl J Med Date: 1999-09-16 Impact factor: 91.245

6. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

Authors: A E Buxton; K L Lee; J D Fisher; M E Josephson; E N Prystowsky; G Hafley
Journal: N Engl J Med Date: 1999-12-16 Impact factor: 91.245

7. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.

Authors: J L Anderson; E M Gilbert; B L Alpert; R W Henthorn; A L Waldo; A K Bhandari; R W Hawkinson; E L Pritchett
Journal: Circulation Date: 1989-12 Impact factor: 29.690

8. Mechanism of the cardiotoxic actions of terfenadine.

Authors: R L Woosley; Y Chen; J P Freiman; R A Gillis
Journal: JAMA Date: 1993 Mar 24-31 Impact factor: 56.272

9. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

Authors: G C Flaker; J L Blackshear; R McBride; R A Kronmal; J L Halperin; R G Hart
Journal: J Am Coll Cardiol Date: 1992-09 Impact factor: 24.094

10. The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.

Authors: J T Lee; H K Kroemer; D J Silberstein; C Funck-Brentano; M D Lineberry; A J Wood; D M Roden; R L Woosley
Journal: N Engl J Med Date: 1990-06-21 Impact factor: 91.245

7 in total

Review 1. Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.

Authors: Armin Barekatain; Mehdi Razavi
Journal: Tex Heart Inst J Date: 2012

2. Disparities in management of new-onset atrial fibrillation in the emergency department despite adherence to the current guidelines: data from a large metropolitan area.

Authors: Francesco Buccelletti; Salvatore Di Somma; Alberto Galante; Francesco Pugliese; Filippo Alegiani; Giuliano Bertazzoni; Nicolò Gentiloni Silveri; Jacopo M Legramante; Francesco Franceschi
Journal: Intern Emerg Med Date: 2011-02-13 Impact factor: 3.397

Review 3. Safety and Interactions of Direct Oral Anticoagulants with Antiarrhythmic Drugs.

Authors: Ipek Celikyurt; Christoph R Meier; Michael Kühne; Beat Schaer
Journal: Drug Saf Date: 2017-11 Impact factor: 5.606

4. Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol.

Authors: Anna Elgart; Irina Cherniakov; Yanir Aldouby; Abraham J Domb; Amnon Hoffman
Journal: Pharm Res Date: 2013-05-18 Impact factor: 4.200

Antiarrhythmic drugs: from mechanisms to clinical practice.